RLYB

Rallybio Corp RLYB

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #204 of 2,925TOP 10%

Why it scores 71Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$0

Quarter to Jun 30

Net income

$43.66M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$65.04M total
ADAR1 Capital Management, LLC
$14.82M+4411.1%
FMR LLC
$12.72M+0.2%
VIKING GLOBAL INVESTORS LP
$8.39M0.0%
TPG GP A, LLC
$6.06M0.0%
Pivotal bioVenture Partners Investment Advisor LLC
$4.81M0.0%
RENAISSANCE TECHNOLOGIES LLC
$3.20M+27.7%
Nantahala Capital Management, LLC
$3.01M-37.3%
VANGUARD CAPITAL MANAGEMENT LLC
$2.76M+54.0%
Almitas Capital LLC
$1.93M-36.9%
Rangeley Capital, LLC
$1.68M+248.0%
CITADEL ADVISORS LLC
$1.16M+263.1%
Mariner, LLC
$809.1K0.0%
JANE STREET GROUP, LLC
$758.8KNew
GEODE CAPITAL MANAGEMENT, LLC
$512.9K-9.5%
BlackRock, Inc.
$485.3K+73.5%
HRT FINANCIAL LP
$410.0KNew
XTX Topco Ltd
$344.0K+91.5%
VANGUARD FIDUCIARY TRUST CO
$269.1K+24.2%
TWO SIGMA INVESTMENTS, LP
$265.9KNew
STATE STREET CORP
$207.9KNew
Quadrature Capital Ltd
$207.9KNew
DIMENSIONAL FUND ADVISORS LP
$180.5K0.0%
Vanguard Global Advisers, LLC
$23.1K0.0%
Hartford Financial Management Inc.
$13.0K0.0%
SBI Securities Co., Ltd.
$8.1K-3.4%
See all 37 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/RLYB

Earnings Per Share

13fpro.ai/company/RLYB

Loading ratio trend…

RLYB key financials by period

Reported revenue, net income and operating margin by fiscal year, from Rallybio Corp's annual filings on SEC EDGAR.

Rallybio Corp reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$858.0K$-9.0M—
FY 2024$636.0K$-57.8M—
Source: RLYB filings on SEC EDGAR →

RLYB insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Rallybio Corp (RLYB): stock profile, AI score and financials

Rallybio Corp (RLYB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores RLYB at 70.5/100 on a composite quality score built from its SEC filings, placing it at rank #204 of 2,925 stocks — the top 10% of the AI-ranked universe. Top institutional holders of RLYB by reported 13-F value include ADAR1 Capital Management, FMR, VIKING GLOBAL INVESTORS, based on the most recent SEC filings. RLYB trades on the Nasdaq exchange and files with the SEC under CIK 1739410. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RLYB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Rallybio Corp directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1739410 →